General Federal Contracts — June 17, 2026

TOTE Services, LLC received a $309.6M firm-fixed-price delivery order from the Maritime Administration for NSMV V, with $264.2M already outlaid (85% funded), indicating strong execution progress and reduced future payment risk. This provides multi-year revenue visibility through August 2029.

Kiewit Infrastructure West Co. won a $103.3M firm-fixed-price contract from the National Park Service for a wastewater treatment plant replacement in Yosemite, with no options and full obligation at award. The fixed-price structure transfers all cost overrun risk to Kiewit for a complex construction project through 2031, with no margin protection.

Leidos Holdings, Inc. subsidiary Leidos Biomedical Research Inc. received a $126.4M cost-plus-fixed-fee delivery order from NIH NCI for GOCO R&D facility space management in Frederick, MD, through August 2024. The cost-plus structure limits margin upside but reduces risk, with $74.2M already outlaid.

TOTE Services faces fixed-price execution risk on the $309.6M NSMV V vessel delivery through 2029, with no cost-plus protection. Any cost overruns or delays could erode margins on a single-vessel contract that represents ~$41.9M annual revenue.

Kiewit Infrastructure West Co. bears high fixed-price execution risk on the $103.3M Yosemite wastewater treatment plant replacement, a complex construction project with no options and full obligation at award. Cost overruns could materially impact margins on a contract representing ~$18.8M annual revenue.

All three contracts were awarded via full-and-open competition with no set-asides, indicating no policy-driven tailwinds for small businesses or 8(a)/SDVOSB/HUBZone entities. This suggests compressed margins as large contractors compete on price/capability.

TOTE Services could secure follow-on NSMV or similar vessel contracts from the Maritime Administration, given the agency's investment in specialized vessel construction and TOTE's demonstrated execution on NSMV V.

Leidos Biomedical Research Inc. could see follow-on GOCO facility management contracts at Frederick, MD, as NIH NCI continues to invest in R&D facility operations. The current contract ends August 2024, creating a re-compete opportunity.

Two of three contracts (TOTE Services and Kiewit Infrastructure West Co.) totaling $412.9M are for civilian infrastructure and construction projects (Maritime Administration vessel and National Park Service wastewater plant), indicating a civilian-heavy procurement day with no defense IT or R&D awards.

All three contracts are firm-fixed-price (TOTE and Kiewit) or cost-plus-fixed-fee (Leidos), with no cost-reimbursable or incentive-fee structures. This shifts cost overrun risk to contractors, particularly for TOTE and Kiewit, which have no margin protection.

{"entity"=>"TOTE Services, LLC", "reason"=>"The $309.6M NSMV V contract is 85% funded but carries fixed-price execution risk through 2029. Any cost overrun or delay could materially impact margins on a single-vessel contract.", "trigger"=>"Cost overrun disclosures or contract modifications"}

{"entity"=>"Kiewit Infrastructure West Co.", "reason"=>"The $103.3M Yosemite WWTP contract has no margin protection and full obligation at award. Any cost overruns on a complex construction project could impact earnings.", "trigger"=>"Quarterly earnings mentions of project cost overruns or delays"}

{"entity"=>"Leidos Holdings, Inc.", "reason"=>"The $126.4M NIH NCI GOCO facility management contract ends August 2024, creating a re-compete opportunity. Any loss of this contract could signal competitive weakness in federal R&D services.", "trigger"=>"Re-compete announcement or contract extension"}